For example, ( +)-naltrexone [( +)-NTX], an antagonist of TLR2 and TLR4, was effective at treating MS-related memory deficits with both lower- and higher-dose in EAE mice but failed to alleviate EAE-induced motor deficits [148]. This evidence concerns the gene TLR2 and myeloid sarcoma.